Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure

Juno Therapeutics, Inc. (JUNO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/07/2018 4 Wilderotter Mary Agnes (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 75,000 options to buy @ $8.72, valued at $654k
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 PIEN HOWARD H (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 12,251 shares @ $0
Gifted 1,162 shares @ $0
Unknown transaction of 111,587 shares @ $87, valued at $9.7M
Disposed/sold 5,050 shares @ $87, valued at $439.4k
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 NELSEN ROBERT (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 50,824 shares @ $87, valued at $4.4M
Disposed/sold 3,234 shares @ $87, valued at $281.4k
Unknown transaction of 10,552,390 shares @ $87, valued at $918.1M
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 LEE ANN L. (EVP, Technical Operations) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 35,004 shares @ $0
Disposed/sold 40,788 shares @ $0
Disposed/sold 35,000 shares @ $0
Disposed/sold 152,900 options to buy @ $62.85, valued at $9.6M
03/07/2018 4 Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 23,250 shares @ $0
Unknown transaction of 705,525 shares @ $87, valued at $61.4M
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 492,355 shares @ $87, valued at $42.8M
Disposed/sold 50,010 shares @ $87, valued at $4.4M
Disposed/sold 20,580 shares @ $0
Disposed/sold 29,135 shares @ $0
Disposed/sold 11,544 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 98,750 options to buy @ $8.72, valued at $861.1k
Disposed/sold 85,000 options to buy @ $48.06, valued at $4.1M
Disposed/sold 155,000 options to buy @ $24.5, valued at $3.8M
Disposed/sold 127,841 options to buy @ $20.76, valued at $2.7M
03/07/2018 4 FLATLEY JAY T (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 31,500 shares @ $87, valued at $2.7M
Disposed/sold 18,000 options to buy @ $24.07, valued at $433.3k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 EVNIN ANTHONY B (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 25,000 shares @ $0
Gifted 34,842 shares @ $0
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Daniel Thomas O (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 5,558 shares @ $87, valued at $483.5k
Disposed/sold 18,293 shares @ $0
Disposed/sold 25,639 shares @ $0
Disposed/sold 35,893 shares @ $0
Unknown transaction of 26,869 shares @ $87, valued at $2.3M
Disposed/sold 125,000 options to buy @ $6.36, valued at $795k
Disposed/sold 37,500 options to buy @ $8.72, valued at $327k
Disposed/sold 50,500 options to buy @ $48.06, valued at $2.4M
Disposed/sold 75,000 options to buy @ $24.5, valued at $1.8M
Disposed/sold 113,636 options to buy @ $20.76, valued at $2.4M
03/07/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 2,263,948 shares @ $87, valued at $197M
Disposed/sold 48,829 shares @ $87, valued at $4.2M
Disposed/sold 33,133 shares @ $0
Disposed/sold 66,426 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 451,756 options to buy @ $6.36, valued at $2.9M
Disposed/sold 140,000 options to buy @ $48.06, valued at $6.7M
Disposed/sold 200,000 options to buy @ $24.5, valued at $4.9M
Disposed/sold 205,823 options to buy @ $20.76, valued at $4.3M
03/07/2018 4 Barron Hal (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 100,000 shares @ $87, valued at $8.7M
Disposed/sold 3,780 shares @ $87, valued at $328.9k
Disposed/sold 75,000 options to buy @ $6.36, valued at $477k
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 7,500 shares @ $0
Disposed/sold 20,580 shares @ $0
Disposed/sold 25,639 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 93,294 options to buy @ $51.76, valued at $4.8M
Disposed/sold 30,002 options to buy @ $25.29, valued at $758.8k
Disposed/sold 98,545 options to buy @ $20.76, valued at $2M
03/07/2018 4 AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 84,549 shares @ $0
Disposed/sold 29,135 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 313,797 options to buy @ $24.01, valued at $7.5M
03/06/2018 3 CELGENE CORP /DE/ (10% Owner) has filed a Form 3 on Juno Therapeutics, Inc.
03/01/2018 4 Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 11,544 shares @ $0
02/15/2018 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/14/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Sold 4,157 shares @ $85.55, valued at $355.6k
02/09/2018 4 Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,704 shares @ $85.49, valued at $145.7k
Gifted 162,790 shares @ $0
02/09/2018 4 Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,528 shares @ $85.49, valued at $130.6k
Gifted 26,634 shares @ $0
02/09/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,346 shares @ $85.49, valued at $371.5k
Gifted 116,280 shares @ $0
02/09/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,700 shares @ $85.49, valued at $230.8k
Sold 3,497 shares @ $85.77, valued at $299.9k
Exercised 834 options to buy @ $25.29, valued at $21.1k
Exercised 2,663 options to buy @ $20.76, valued at $55.3k
02/02/2018 4 LEE ANN L. (EVP, Technical Operations) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 40,788 shares @ $0
02/02/2018 4 Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 29,135 shares @ $0
02/02/2018 4 Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 25,639 shares @ $0
02/02/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 66,426 shares @ $0
02/02/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 25,639 shares @ $0
Sold 4,167 shares @ $85.78, valued at $357.4k
Exercised 4,167 options to buy @ $51.76, valued at $215.7k
02/02/2018 4 AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 29,135 shares @ $0
01/30/2018 4 FLATLEY JAY T (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Bought 10,000 shares @ $22.92, valued at $229.2k
01/24/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Sold 102,539 shares @ $86.25, valued at $8.8M
Exercised 102,539 options to buy @ $51.76, valued at $5.3M
01/19/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Sold 21,141 shares @ $68.1, valued at $1.4M
Sold 7,990 shares @ $69.95, valued at $558.9k
Exercised 2,498 options to buy @ $25.29, valued at $63.2k
Exercised 26,633 options to buy @ $20.76, valued at $552.9k
01/18/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Sold 65,820 shares @ $44.7163, valued at $2.9M
Sold 89,888 shares @ $45.5321, valued at $4.1M
Sold 49,082 shares @ $46.5247, valued at $2.3M
Sold 23,003 shares @ $47.6925, valued at $1.1M
Sold 42,457 shares @ $48.5648, valued at $2.1M
Exercised 245,750 options to buy @ $6.36, valued at $1.6M
01/09/2018 4 PIEN HOWARD H (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 25,000 shares @ $0
Granted 417 shares @ $0
01/09/2018 4 NELSEN ROBERT (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 237 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy